Back

Discussion - Imaging – A Must or an Add-on in Risk Assessment?

10 November 2019 (09:55 - 10:00)
Organised by:
Congress Presentation Part of: How to Assess Cardiovascular Risk in Clinical Practice? Cardiovascular Risk Assessment ESC Premium Access ESC Asia with APSC & AFC

5 More presentations in this session

Presentation thumbnail
Risk Scores: Advantages and Pitfalls.
Professor S. Gielen (Detmold, DE)
Slides Video
Presentation thumbnail
Discussion - Risk Scores: Advantages and Pitfalls
Presentation thumbnail
Biomarkers in Risk Assessment: Lipids and Beyond.
Doctor A. Fong (Kuching, MY)
Slides Video
Presentation thumbnail
Discussion - Biomarkers in Risk Assessment: Lipids and Beyond.
Presentation thumbnail
Imaging – A Must or an Add-on in Risk Assessment?
Professor M. Marwan (Erlangen, DE)
Slides Video

Access the full session

Session thumbnail
How to Assess Cardiovascular Risk in Clinical Practice?

The Event

Event poster

ESC Asia with APSC & AFC

10 November 2019 09:55 CET
You may be interested in
thumbnail
Webinar
The role of imaging in cardiovascular disease prevention
23 March 2022
thumbnail
Congress Session
Great Debate: assessing the risk of sudden death in hypertrophic cardiomyopathy should include myocardial fibrosis imaging
1 September 2024
thumbnail
Webinar
Cardiac sarcoidosis: the multimodality imaging approach
25 April 2023
thumbnail
Congress Session
How to assess patients after transcatheter valve procedures
12 December 2024

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources